During the past decade, Crio - Centro Regional Integrado de Oncologia conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 7 clinical trials were completed, i.e. on average, 29.2% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 3 clinical trials were completed. i.e. 27.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Crio - Centro Regional Integrado de Oncologia" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Latin American Cooperative Oncology Group" with 6 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 3 trials sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored and "Agenus Inc." with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Crio - Centro Regional Integrado de Oncologia" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Latin American Cooperative Oncology Group" with 2 trials as a collaborator and "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Crio - Centro Regional Integrado de Oncologia" are "Breast Cancer" (5 trials), "Metastatic Breast Cancer" (3 trials), "Head and Neck Cancer" (2 trials), "Head and Neck Neoplasms" (2 trials) and "Non-small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "Crio - Centro Regional Integrado de Oncologia" in a lesser frequency.

Most popular intervention types in "Crio - Centro Regional Integrado de Oncologia" are "Drug" (22 trials), "Biological" (6 trials), "Radiation" (4 trials), "Other" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Atezolizumab" (5 trials), "Cisplatin" (4 trials), "Paclitaxel" (4 trials) and "Gemcitabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Crio - Centro Regional Integrado de Oncologia" are 21 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Crio - Centro Regional Integrado de Oncologia". undefined are not yet recruiting, 9 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Crio - Centro Regional Integrado de Oncologia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Crio - Centro Regional Integrado de Oncologia, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".